ABCR  Vol.5 No.3 , July 2016
Quantitative Assessment of Chronic Skin Reactions Including Erythema and Pigmentation after Breast Conserving Therapy
Abstract: Purpose: To evaluate long-term skin reactions following breast-conserving therapy by using the melanin-erythema index meter. Patients and Methods: 164 patients were followed for at least three years after breast-conserving therapy. For both the erythema and the melanin indices, the ratio of the irradiated-side index to the non-irradiated-side index was calculated. The time course of index ratios alternation was examined. Influences from additional therapies and patients’ age were also evaluated. Result: Both erythema and melanin index ratios of the breast skin were recovered to pre-radiation level three years after radiotherapy. However, both index ratios of the area administrated with 10-Gy boost irradiation were still high even after five years after radiotherapy. Endocrine therapy, chemotherapy and age had no significant influence on skin color reactions three years after radiotherapy. Conclusion: Quantitative assessment using the melanin-erythema index meter demonstrated that chronic skin reactions following breast conserving therapy had recovered to pre-radiation level for three years after irradiation except for the 10-Gy boost irradiated area.
Cite this paper: Kawashima, M. , Nozaki, M. , Komazaki, K. , Yamamuro, R. , Ishizuna, K. and Kojima, M. (2016) Quantitative Assessment of Chronic Skin Reactions Including Erythema and Pigmentation after Breast Conserving Therapy. Advances in Breast Cancer Research, 5, 121-128. doi: 10.4236/abcr.2016.53014.

[1]   Early Breast Cancer Trialists’ Group (2005) Effect of Radiotherapy and of Differences in the Extent of Surgery for Early Breast Cancer on Local Recurrence and 15-Year Survival: An Overview of the Randomized Trials. The Lancet, 366, 2087-2106.

[2]   Fisher, B., Anderson, S., Bryant, J., Margolese, R.G., Deutsch, M., Fisher, E.R., Jeong, J.H. and Wolmark, N. (2002) Twenty-Year Follow-Up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer. The New England Journal of Medicine, 347, 1233-1241.

[3]   Ohsumi, S., Sakamoto, G., Takashima, S., Koyama, H., Shin, E., Suemasu, K., Nishi, T., Nakamura, S., Iino, Y., Iwase, T., Ikeda, T., Teramoto, S., Fukutomi, T., Komaki, K., Sano, M., Sugiyama, K., Miyoshi, K., Kamio, T. and Ogita, M. (2003) Long-Term Results of Breast-Conserving Treatment for Early-Stage Breast Cancer in Japanese Women from Multicenter Investigation. Japanese Journal of Clinical Oncology, 33, 61-67.

[4]   Engel, J., Kerr, J., Schlesinger-Raab, A., Sauer, H. and Holzel, D. (2004) Quality of Life Following Breast-Conserving Therapy or Mastectomy: Result of a 5-Year Prospective Study. The Breast Journal, 10, 223-231.

[5]   Takashima, S., Koyama, H., Kasumi, F., Kimijima, I., Ohkawa, T., Takatsuka, Y., Okumura, K., Kodama, H., Nishi, T., Sano, M., Fukutomi, T. and Kobayashi, S. (1995) Evaluation of the Quality of Life in Breast Cancer Patients Treated with Breast-Conserving Therapy. Journal of Japan Society for Cancer Therapy, 30, 1641-1652. (In Japanese with English Abstract)

[6]   Hymes, S.R., Strom, E.A. and Fife, C. (2006) Radiation Dermatitis: Clinical Presentation, Pathophysiology, and Treatment. Journal of the American Academy of Dermatology, 54, 28-46.

[7]   Archambeau, J.O., Pezner, R. and Wasserman, T. (1995) Patholosiology of Irradiated Skin and Breast. International Journal of Radiation Oncology * Biology * Physics, 31, 1171-1185.

[8]   Hipewell, J.W. (1990) The Skin: Its Structure and Response to Ionizing Radiation. International Journal of Radiation Oncology * Biology * Physics, 57, 751-773.

[9]   National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) and Common Toxicity Criteria (CTC).

[10]   Pavy, J.J., Denekamp, J., Letschert, J., Littbrand, B., Mornex, F., Bernier, J., Gonzales-Gonzales, D., Horiot, J.C., Bolla, M. and Bartelink, H. (1995) EORTC Late Effects Working Group. Late Effects Toxicity Scoring: The SOMA Scale. International Journal of Radiation Oncology * Biology * Physics, 31, 1043-1047.

[11]   Kawashima, M., Nozaki, M., Furuta, M., Nakamura, M., Komazaki, K. and Izawa, Y. (2007) Objective Assessment of Breast Skin Reactions after Breast-Conserving Therapy. JASTRO Japanese Society for Radiation Oncology, 19, 58-64.

[12]   Clarys, P., Alewaeters, K., Lambrecht, R. and Barel, A.O. (2000) Skin Color Measurements: Comparison between Three Instruments: The Chromameter®, the Derma Specrometer®, and the Mexameter®. Skin Research and Technology, 6, 230-238.

[13]   Benediktson, K.P., Celebioglu, F. and Perkbeck, L.G. (1997) Influence of Radiation Therapy on Skin Circulation in Breast after Breast Conservative Surgery. Acta Oncologica, 36, 715-718.

[14]   Inomata, T., Ogawa, Y., Nishioka, A., Terashima, M., Kariya, S., Mesaki, K., Fukumoto, M. and Yoshida, S. (1995) Changes in Blood Flow and Skin Reaction Following Radiation Therapy. Nippon Acta Radiologica, 55, 58-64. (In Japanese with English Abstract)

[15]   Sekine, H., Kobayashi, M., Honda, C., Aoki, M., Nakagawa, M. and Kanehira, C. (2000) Skin Reactions after Breast-Conserving Therapy and Prediction of Late Complications Using Physiological Functions. Breast Cancer, 7, 142-148.

[16]   Yoshida, K., Yamazaki, H., Takenaka, T., Tanaka, E., Kotsuma, T., Fujita, Y., Masuda, N., Kuriyama, K., Yoshida, M. and Nishimura, T. (2010) Objective Assessment of Dermatitis Following Post-Operative Radiotherapy in Patients with Breast Cancer Treated with Breast-Conserving Treatment. Strahlentherapie und Onkologie, 86, 621-629.

[17]   Dolotov, L.E., Sinichkin, Y.P., Tuchin, V.V., Utz, S.R., Altshuler, G.B. and Yaroslavsky, I.V. (2004) Design and Evaluation of a Novel Portable Erythema-Melanin-Meter. Lasers in Surgery and Medicine, 34, 127-135.

[18]   Takiwaki, H., Shirai, S., Kanno, Y., Watanebe, Y. and Arase, S. (1994) Quantification of Erythema and Pigmentation Using a Videomicroscope and a Computer. British Journal of Dermatology, 131, 85-92.

[19]   Okumura, S., Mitsumori, M., Kokubo, M., Yamauchi, C., Kawamura, S., Oya, N., Nagata, Y. and Hiraoka, M. (2003) Late Skin and Subcutaneous Soft Tissue Changes after 10-Gy Boost for Breast Conserving Therapy. Breast Cancer, 10, 129-133.

[20]   Romestaing, P., Lehingue, Y., Carrie, C., Coquard, R., Montbarbon, X., Ardiet, J.M., Mamelle, N. and Gérard, J.P. (1997) Role of a 10-Gy Boost in the Conservative Treatment of Early Breast Cancer: Result of a Randomized Trial in Lyon, France. Journal of Clinical Oncology, 15, 963-968.